Literature DB >> 19427709

[Clinical profile and management patterns in outpatients with heart failure in Spain: INCA study].

Beatriz de Rivas Otero1, Gaieta Permanyer-Miralda, Carlos Brotons Cuixart, Joaquin Aznar Costa, Eduardo Sobreviela Blázquez.   

Abstract

AIM: To assess clinical characteristics and treatment management of out-patients with chronic heart failure (CHF) in Spain.
DESIGN: Cross-sectional study. LOCATION: Primary care (PC) centres and cardiology out-patient clinics. PATIENTS: CHF patients (all had an echocardiography performed).
METHODS: Data were collected from consecutive patients who attended clinics (93 cardiologist and 415 PC physicians) with a diagnosis of CHF during June 2006.
RESULTS: The study subjects were 2161 CHF patients (1412 PC; 749 Cardiology), with a mean age was 70.9+/-10.6 years and 55.62% were males. Patients followed up in cardiology were younger, the majority were male, had a better functional class, lower ejection fraction, and fewer co-morbidities than those followed up in PC. The most used treatments were drugs that block the renin-angiotensin system (ACEi or ARB) (89.4%) and diuretics (84.91%), followed by beta-blockers (43.96%). Blood pressure (< 130/80 mmHg) was controlled in 24.93% of the patients, and diabetes mellitus in 32.33% of the diabetics (HbA(1c)<6.5%). Both risk factors were significantly better in PC.
CONCLUSIONS: The INCA results show different clinical characteristics between patients followed up in the two health care levels. The pharmacological treatment has improved since previous studies and is closer to that recommended in chronic heart failure guidelines. Nevertheless, blood pressure and diabetes mellitus control are still insufficient.

Entities:  

Mesh:

Year:  2009        PMID: 19427709      PMCID: PMC7022016          DOI: 10.1016/j.aprim.2008.10.022

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  15 in total

Review 1.  The heart failure epidemic: exactly how big is it?

Authors:  J G Cleland; A Khand; A Clark
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

2.  [European study of ambulatory management of heart failure by cardiologists].

Authors:  María J Salvador; Alain Sebaoun; Frank Sonntag; Pedro Blanch; Sigmund Silber; Joaquín Aznar; Michel Komajda
Journal:  Rev Esp Cardiol       Date:  2004-12       Impact factor: 4.753

3.  [Clinical characteristics, treatment and short-term morbidity and mortality of patients with heart failure followed in heart failure clinics. Results of the BADAPIC Registry].

Authors:  Manuel Anguita Sánchez
Journal:  Rev Esp Cardiol       Date:  2004-12       Impact factor: 4.753

4.  [Impact of hypertension in cardiac diseases in Spain. The CARDIOTENS Study 1999].

Authors:  J R Juanatey; E A Ezquerra; J V Vidal; J L Caro; J G Acuña; I G Maqueda
Journal:  Rev Esp Cardiol       Date:  2001-02       Impact factor: 4.753

5.  Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

Authors:  J G F Cleland; A Cohen-Solal; J Cosin Aguilar; R Dietz; J Eastaugh; F Follath; N Freemantle; A Gavazzi; W H van Gilst; F D R Hobbs; J Korewicki; H C Madeira; I Preda; K Swedberg; J Widimsky
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

6.  [Clinical characteristics of patients diagnosed of chronic heart failure attended in Primary Care. The CARDIOPRES study].

Authors:  G C Rodríguez Roca; V Barrios Alonso; J Aznar Costa; J L Llisterri Caro; F J Alonso Moreno; C Escobar Cervantes; S Lou Arnal; J A Divisón Garrote; N Murga Eizagaechevarría; A Matalí Gilarranz
Journal:  Rev Clin Esp       Date:  2007 Jul-Aug       Impact factor: 1.556

Review 7.  [Epidemiology of heart failure].

Authors:  Fernando Rodríguez-Artalejo; José R Banegas Banegas; Pilar Guallar-Castillón
Journal:  Rev Esp Cardiol       Date:  2004-02       Impact factor: 4.753

8.  Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.

Authors:  Aldo P Maggioni; Inder Anand; Sidney O Gottlieb; Roberto Latini; Gianni Tognoni; Jay N Cohn
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

9.  [Galician study of heart failure in primary care (GALICAP Study)].

Authors:  Fernando Otero-Raviña; Lilian Grigorian-Shamagian; Luis Fransi-Galiana; Carlos Názara-Otero; José M Fernández-Villaverde; Alberto del Alamo-Alonso; Enrique Nieto-Pol; Miguel de Santiago-Boullón; Isidro López-Rodríguez; José M Cardona-Vidal; Alfonso Varela-Román; José R González-Juanatey
Journal:  Rev Esp Cardiol       Date:  2007-04       Impact factor: 4.753

10.  Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice.

Authors:  Frans H Rutten; Diederick E Grobbee; Arno W Hoes
Journal:  Eur J Heart Fail       Date:  2003-06       Impact factor: 15.534

View more
  4 in total

1.  [Heart failure patients in Primary Care: aging, comorbidities and polypharmacy].

Authors:  Gisela Galindo Ortego; Inés Cruz Esteve; Jordi Real Gatius; Leonardo Galván Santiago; Carmen Monsó Lacruz; Plácido Santafé Soler
Journal:  Aten Primaria       Date:  2010-12-22       Impact factor: 1.137

2.  [INCA study: cardiac failure or vascular risk?].

Authors:  Manuel Méndez Bailón; Nuria Muñoz Rivas
Journal:  Aten Primaria       Date:  2009-10-07       Impact factor: 1.137

3.  [Beta-blockers in the treatment of heart failure: when do we give them?].

Authors:  Jesús Iturralde Iriso
Journal:  Aten Primaria       Date:  2009-11-18       Impact factor: 1.137

4.  [Survival of patients with heart failure in primary care].

Authors:  Antonio Sarría-Santamera; Francisco Javier Prado-Galbarro; María Auxiliadora Martín-Martínez; Rocío Carmona; Ana Estela Gamiño Arroyo; Carlos Sánchez-Piedra; Sofía Garrido Elustondo; Isabel del Cura González
Journal:  Aten Primaria       Date:  2014-12-06       Impact factor: 1.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.